Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost (Travatan Z) vs Latanoprost (Xalatan) Ocular Surface Effects
NCT00708422Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2008
- Primary completion
- Aug 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 4 trial of travoprost in Glaucoma, ocular hypertension, sponsored by Alcon Inc.. Started Jul 2008; status: completed.
02
Drugs
travoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00708422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708422.